Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case-control study

Pediatric ObesityWang Y, et al. | February 15, 2013

Advertisement

Current clinical guidelines to assess paediatric cardiovascular disease (CVD) risk heavily rely on cholesterol parameters that are generally normal for obese children. Remnant lipoproteins have emerged as a critical CVD risk factor particularly in adults with normolipidemia. Elevated apoB48–containing remnant lipoprotein is a stronger biomarker for paediatric CVD risk compared to traditional cholesterol parameters and may be associated with early adaptation of the intestine during obesity. Further investigation of abnormalities associated with the secretion and/or clearance of atherogenic remnant lipoproteins during the postprandial state may yield insight into the understanding of and therapeutic targets for managing risk for CVD in children with obesity.

Read the full article on Pediatric Obesity

Advertisement